AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
TIROFIBAN
4 registrations across 3 African markets— 3 active
Markets with TIROFIBAN
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| RIBOFAN 12,5 MG / 50 ML IV SOLUTION A DILUER PERFUSION BOITE DE 1 FLACON DE 50 ML | 🇨🇮Côte d'Ivoire | LABORATOIRE MS PHARMA | expired | Feb 2024 |
| AGRASTAT 50 MICROGRAMMES/ML SOLUTION POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| AGRASTAT 250 MICROGRAMMES/ML SOLUTION A DILUER POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| Ribofan Solution for injection | 🇹🇿Tanzania | MS Pharma Jordan | active | — |
TIROFIBAN in Africa — Regulatory Overview
TIROFIBAN is registered across 3 African markets with 4 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Morocco, Côte d'Ivoire, Tanzania. AfricaRegulatory refreshes this data daily from official government sources.
Of the 4 registrations, 3 (75%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.